2026-2030年全球远距临床试验监查工具市场

全球远距临床试验监查工具市场预计在 2025 年至 2030 年间成长 51.856 亿美元，预测期内复合年增长率为 23.5%。

本报告对全球远距临床试验监查工具市场进行了全面分析，包括市场规模和预测、趋势、成长要素和挑战，以及对约 25 家公司的供应商分析。

该报告对当前市场格局、最新趋势和驱动因素以及整体市场环境进行了最新分析，其驱动因素包括分散式和混合式临床试验模式的兴起、不断发展的框架和对基于风险的监测的关注，以及人工智慧和云端运算的技术融合。

本研究采用客观的方法，结合一手和二手讯息，包括来自主要行业相关人员的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告提供历史数据和预测数据。

研究指出，将预测分析和机器学习技术应用于监测是未来几年推动全球远距临床试验监测工具市场成长的主要因素之一。此外，穿戴式科技的日益普及、持续病患监测的日益重要，以及远端来源资料检验和互通性标准的不断提高，预计也将显着提升市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 价格、生命週期、顾客购买篮、采用率和购买标准分析
• 投入与差异化因素的重要性
• 混淆来源
• 驱动因素和挑战的影响

第三章 市场情势

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模表现

• 2020-2024年全球远距临床试验监查工具市场
• 零件细分市场分析 2020-2024
• 2020-2024年最终用户细分市场分析
• 2020-2024年部署细分市场分析
• 2020-2024年区域市场分析
• 2020-2024年国家细分市场分析

第六章 定性分析

• 人工智慧的影响：全球远距临床试验监查工具市场

第七章五力分析

• 五力分析概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

8. 按组件进行市场细分

• 比较：按组件
• 软体
• 硬体
• 服务
• 按组件分類的市场机会

9. 按最终用户进行市场区隔

• 比较：按最终用户
• 製药和生物技术公司
• 合约研究机构
• 医疗保健IT和服务供应商
• 学术研究机构
• 按最终用户分類的市场机会

第十章 依部署方式进行市场区隔

• 比较：依部署方式
• 基于云端的
• 本地部署
• 按部署方式分類的市场机会

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 荷兰
  • 西班牙
  • 俄罗斯
• 亚洲
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 新加坡
• 世界其他地区
  • 澳洲
  • 阿拉伯聯合大公国
  • 巴西
  • 南非
  • 沙乌地阿拉伯
  • 土耳其
• 各区域的市场机会

第十三章：驱动因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 令人困惑的局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 企业排名指数
• 公司市场定位
• Advarra Inc.
• Anju Software Inc.
• Castor Research Inc.
• Cloudbyz Inc.
• Ennov SAS
• Florence Healthcare.
• IQVIA Holdings Inc.
• Medable Inc.
• Medidata
• Medrio Inc.
• Merative LP
• Microsoft Corp.
• Obvio Health USA Inc.
• OpenClinica LLC
• Oracle Corp.

第十六章附录

The global remote clinical trial monitoring tools market is forecasted to grow by USD 5185.6 mn during 2025-2030, accelerating at a CAGR of 23.5% during the forecast period. The report on the global remote clinical trial monitoring tools market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise of decentralized and hybrid clinical trial models, evolving frameworks and emphasis on risk-based monitoring, technological integration of AI and cloud computing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global remote clinical trial monitoring tools market is segmented as below:

By Component

• Software
• Hardware
• Services

By End-User

• Pharmaceutical and biotech companies
• Contract research organizations
• Healthcare IT and service providers
• Academic and research institutes

By Deployment

• Cloud based
• On premises

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of predictive analytics and ml in monitoring as one of the prime reasons driving the global remote clinical trial monitoring tools market growth during the next few years. Also, proliferation of wearable technology and continuous patient monitoring and standardization of remote source data verification and interoperability will lead to sizable demand in the market.

The report on the global remote clinical trial monitoring tools market covers the following areas:

• Global remote clinical trial monitoring tools market sizing
• Global remote clinical trial monitoring tools market forecast
• Global remote clinical trial monitoring tools market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global remote clinical trial monitoring tools market vendors that include Advarra Inc., Anju Software Inc., Castor Research Inc., Cloudbyz Inc., Ennov SAS, Florence Healthcare., IQVIA Holdings Inc., Medable Inc., Medidata, Medrio Inc., Merative L.P., Microsoft Corp., Obvio Health USA Inc., OpenClinica LLC, Oracle Corp., Salesforce Inc., SAP SE, Signant Health, Veeva Systems Inc., Zoom Video Communications Inc.. Also, the global remote clinical trial monitoring tools market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Deployment
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Remote Clinical Trial Monitoring Tools Market 2020 - 2024
  • Historic Market Size - Data Table on Global Remote Clinical Trial Monitoring Tools Market 2020 - 2024 ($ million)
• 5.2 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Deployment segment analysis 2020 - 2024
  • Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Remote Clinical Trial Monitoring Tools Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Component

• 8.1 Market segments
• 8.2 Comparison by Component
• 8.3 Software - Market size and forecast 2025-2030
• 8.4 Hardware - Market size and forecast 2025-2030
• 8.5 Services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Component
  • Market opportunity by Component ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharmaceutical and biotech companies - Market size and forecast 2025-2030
• 9.4 Contract research organizations - Market size and forecast 2025-2030
• 9.5 Healthcare IT and service providers - Market size and forecast 2025-2030
• 9.6 Academic and research institutes - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Deployment

• 10.1 Market segments
• 10.2 Comparison by Deployment
• 10.3 Cloud based - Market size and forecast 2025-2030
• 10.4 On premises - Market size and forecast 2025-2030
• 10.5 Market opportunity by Deployment
  • Market opportunity by Deployment ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.5.7 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 Brazil - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rise of decentralized and hybrid clinical trial models
  • Evolving frameworks and emphasis on risk-based monitoring
  • Technological integration of AI and cloud computing
• 13.2 Market challenges
  • Data security and cybersecurity vulnerabilities
  • Interoperability and system integration complexity
  • Regulatory heterogeneity and site-level implementation barriers
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of predictive analytics and ML in monitoring
  • Proliferation of wearable technology and continuous patient monitoring
  • Standardization of remote source data verification and interoperability

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Advarra Inc.
  • Advarra Inc. - Overview
  • Advarra Inc. - Product / Service
  • Advarra Inc. - Key offerings
  • SWOT
• 15.5 Anju Software Inc.
  • Anju Software Inc. - Overview
  • Anju Software Inc. - Product / Service
  • Anju Software Inc. - Key offerings
  • SWOT
• 15.6 Castor Research Inc.
  • Castor Research Inc. - Overview
  • Castor Research Inc. - Product / Service
  • Castor Research Inc. - Key offerings
  • SWOT
• 15.7 Cloudbyz Inc.
  • Cloudbyz Inc. - Overview
  • Cloudbyz Inc. - Product / Service
  • Cloudbyz Inc. - Key offerings
  • SWOT
• 15.8 Ennov SAS
  • Ennov SAS - Overview
  • Ennov SAS - Product / Service
  • Ennov SAS - Key offerings
  • SWOT
• 15.9 Florence Healthcare.
  • Florence Healthcare. - Overview
  • Florence Healthcare. - Product / Service
  • Florence Healthcare. - Key offerings
  • SWOT
• 15.10 IQVIA Holdings Inc.
  • IQVIA Holdings Inc. - Overview
  • IQVIA Holdings Inc. - Business segments
  • IQVIA Holdings Inc. - Key offerings
  • IQVIA Holdings Inc. - Segment focus
  • SWOT
• 15.11 Medable Inc.
  • Medable Inc. - Overview
  • Medable Inc. - Product / Service
  • Medable Inc. - Key offerings
  • SWOT
• 15.12 Medidata
  • Medidata - Overview
  • Medidata - Product / Service
  • Medidata - Key offerings
  • SWOT
• 15.13 Medrio Inc.
  • Medrio Inc. - Overview
  • Medrio Inc. - Product / Service
  • Medrio Inc. - Key offerings
  • SWOT
• 15.14 Merative L.P.
  • Merative L.P. - Overview
  • Merative L.P. - Product / Service
  • Merative L.P. - Key offerings
  • SWOT
• 15.15 Microsoft Corp.
  • Microsoft Corp. - Overview
  • Microsoft Corp. - Business segments
  • Microsoft Corp. - Key news
  • Microsoft Corp. - Key offerings
  • Microsoft Corp. - Segment focus
  • SWOT
• 15.16 Obvio Health USA Inc.
  • Obvio Health USA Inc. - Overview
  • Obvio Health USA Inc. - Product / Service
  • Obvio Health USA Inc. - Key offerings
  • SWOT
• 15.17 OpenClinica LLC
  • OpenClinica LLC - Overview
  • OpenClinica LLC - Product / Service
  • OpenClinica LLC - Key offerings
  • SWOT
• 15.18 Oracle Corp.
  • Oracle Corp. - Overview
  • Oracle Corp. - Business segments
  • Oracle Corp. - Key news
  • Oracle Corp. - Key offerings
  • Oracle Corp. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations